Experimental strategy of animal trial for the approval of anti-diabetic agents prior to their use in pre-human clinical trials
DOI:
https://doi.org/10.3329/bjp.v11i1.25762Keywords:
Blood glucose level, Diabetes induction, Diabetes mellitus, Experimental miceAbstract
Although several naturally available drugs have been historically used for the treatment of diabetes mellitus throughout the world, few of them have been validated by scientific criteria. Before approval of any drug developed it should pass through animal trial prior to clinical human trial, which should followed by some standard ethical rules. Recently, a large diversity of animal models have been developed to better understand the pathogenesis of diabetes mellitus, and new drugs have been introduced in the market to treat this autoimmune disease. In the present article, we demonstrated some standard handling procedure of animal trial for the approval of anti-diabetic drug, which could be helpful for both academics and industrial scientific community to conduct the animal experiments. This research also contributes in the field of ethnopharmacology to design new strategies for the development of novel drugs to treat this serious condition of diabetes mellitus that constitutes a global public health.
Video Clip of Methodology:
Handling and caring of mice: 2 min 30 sec Full Screen Alternate
Inducing diabetes in mice and observing blood glucose level: 1 min 47 sec Full Screen Alternate
Drug administration and observation of blood glucose level: 2 min 11 sec Full Screen Alternate
Downloads
314
202
References
Aley KO, Levine JD. Rapid onset pain induced by intravenous streptozotocin in the rat. J Pain. 2001; 2: 146-50.
CCAC. Guide to the care and used of experimental animals. Vol. 1. The Canadian Council on Animal Care, 1993.
Courteix C, Eschalier A, Lavarenne J. Streptozotocin-induced diabetic rats: Behavioral evidence for a model of chronic pain. Pain 1993; 53: 81-88.
Cunha JM, Funez MI, Cunha FQ, Parada CA, Ferreira SH. Streptozotocin induced mechanical hypernociception is not dependent on hyperglycemia. Braz J Med Biol Res. 2009; 42: 197-206.
Frode TS, Medeiros YS. Animal models to test drugs with potential anti-diabetic activity. J Ethnopharmacol. 2008; 115: 173-83.
Shukla S, Mehta P, Bajpai VK. Evaluation of comparative anti-diabetic effects of ethanolic extracts of Caesalpinia bouncucella and Stevia rebaudiana in normal and alloxan-induced experimental rats. Rom Biotechnol Lett. 2011; 16: 6187-99.
Soumyanath A. Traditional medicines for modern times: Anti-diabetic plants. London, CRC Press, 2006.
Turner MA. Screening methods in pharmacology. New York, Academic Press, 1965, p 26.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).